<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-03-29" modified="2017-04-12" version="165">
<accession>Q13535</accession>
<accession>Q59HB2</accession>
<accession>Q7KYL3</accession>
<accession>Q93051</accession>
<accession>Q9BXK4</accession>
<name>ATR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein kinase ATR</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Ataxia telangiectasia and Rad3-related protein</fullName>
</alternativeName>
<alternativeName>
<fullName>FRAP-related protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ATR</name>
<name type="synonym">FRP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="EMBO J." volume="15" first="6641" last="6651">
<title>The Schizosaccharomyces pombe rad3 checkpoint gene.</title>
<authorList>
<person name="Bentley N.J."/>
<person name="Holtzman D.A."/>
<person name="Flaggs G."/>
<person name="Keegan K.S."/>
<person name="DeMaggio A."/>
<person name="Ford J.C."/>
<person name="Hoekstra M."/>
<person name="Carr A.M."/>
</authorList>
<dbReference type="PubMed" id="8978690"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="2850" last="2855">
<title>cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein.</title>
<authorList>
<person name="Cimprich K.A."/>
<person name="Shin T.B."/>
<person name="Keith C.T."/>
<person name="Schreiber S.L."/>
</authorList>
<dbReference type="PubMed" id="8610130"/>
<dbReference type="DOI" id="10.1073/pnas.93.7.2850"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Gene" volume="272" first="35" last="43">
<title>Evidence for alternate splicing within the mRNA transcript encoding the DNA damage response kinase ATR.</title>
<authorList>
<person name="Mannino J.L."/>
<person name="Kim W.-J."/>
<person name="Wernick M."/>
<person name="Nguyen S.V."/>
<person name="Braquet R."/>
<person name="Adamson A.W."/>
<person name="Den Z."/>
<person name="Batzer M.A."/>
<person name="Collins C.C."/>
<person name="Brown K.D."/>
</authorList>
<dbReference type="PubMed" id="11470508"/>
<dbReference type="DOI" id="10.1016/S0378-1119(01)00543-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 433-526 (ISOFORMS 1 AND 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2155-2644 (ISOFORM 3)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Genes Dev." volume="10" first="2423" last="2437">
<title>The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes.</title>
<authorList>
<person name="Keegan K.S."/>
<person name="Holtzman D.A."/>
<person name="Plug A.W."/>
<person name="Christenson E.R."/>
<person name="Brainerd E.E."/>
<person name="Flaggs G."/>
<person name="Bentley N.J."/>
<person name="Taylor E.M."/>
<person name="Meyn M.S."/>
<person name="Moss S.B."/>
<person name="Carr A.M."/>
<person name="Ashley T."/>
<person name="Hoekstra M.F."/>
</authorList>
<dbReference type="PubMed" id="8843195"/>
<dbReference type="DOI" id="10.1101/gad.10.19.2423"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1998" name="Cancer Res." volume="58" first="4375" last="4382">
<title>Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.</title>
<authorList>
<person name="Sarkaria J.N."/>
<person name="Tibbetts R.S."/>
<person name="Busby E.C."/>
<person name="Kennedy A.P."/>
<person name="Hill D.E."/>
<person name="Abraham R.T."/>
</authorList>
<dbReference type="PubMed" id="9766667"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="159" last="169">
<title>Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints.</title>
<authorList>
<person name="Cliby W.A."/>
<person name="Roberts C.J."/>
<person name="Cimprich K.A."/>
<person name="Stringer C.M."/>
<person name="Lamb J.R."/>
<person name="Schreiber S.L."/>
<person name="Friend S.H."/>
</authorList>
<dbReference type="PubMed" id="9427750"/>
<dbReference type="DOI" id="10.1093/emboj/17.1.159"/>
</citation>
<scope>FUNCTION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF ASP-2475</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="7445" last="7450">
<title>Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control.</title>
<authorList>
<person name="Wright J.A."/>
<person name="Keegan K.S."/>
<person name="Herendeen D.R."/>
<person name="Bentley N.J."/>
<person name="Carr A.M."/>
<person name="Hoekstra M.F."/>
<person name="Concannon P."/>
</authorList>
<dbReference type="PubMed" id="9636169"/>
<dbReference type="DOI" id="10.1073/pnas.95.13.7445"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-2494</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Biochemistry" volume="38" first="14711" last="14717">
<title>Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4.</title>
<authorList>
<person name="Schmidt D.R."/>
<person name="Schreiber S.L."/>
</authorList>
<dbReference type="PubMed" id="10545197"/>
<dbReference type="DOI" id="10.1021/bi991614n"/>
</citation>
<scope>INTERACTION WITH HDAC2</scope>
<scope>IDENTIFICATION IN A COMPLEX CONTAINING HDAC2 AND CHD4</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Genes Dev." volume="13" first="152" last="157">
<title>A role for ATR in the DNA damage-induced phosphorylation of p53.</title>
<authorList>
<person name="Tibbetts R.S."/>
<person name="Brumbaugh K.M."/>
<person name="Williams J.M."/>
<person name="Sarkaria J.N."/>
<person name="Cliby W.A."/>
<person name="Shieh S.-Y."/>
<person name="Taya Y."/>
<person name="Prives C."/>
<person name="Abraham R.T."/>
</authorList>
<dbReference type="PubMed" id="9925639"/>
<dbReference type="DOI" id="10.1101/gad.13.2.152"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-2327 AND ASP-2475</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="37538" last="37543">
<title>Substrate specificities and identification of putative substrates of ATM kinase family members.</title>
<authorList>
<person name="Kim S.-T."/>
<person name="Lim D.-S."/>
<person name="Canman C.E."/>
<person name="Kastan M.B."/>
</authorList>
<dbReference type="PubMed" id="10608806"/>
<dbReference type="DOI" id="10.1074/jbc.274.53.37538"/>
</citation>
<scope>COFACTOR</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="6707" last="6713">
<title>ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.</title>
<authorList>
<person name="Hall-Jackson C.A."/>
<person name="Cross D.A.E."/>
<person name="Morrice N."/>
<person name="Smythe C."/>
</authorList>
<dbReference type="PubMed" id="10597277"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203077"/>
</citation>
<scope>FUNCTION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF ASP-2494</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="1448" last="1459">
<title>Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.</title>
<authorList>
<person name="Liu Q."/>
<person name="Guntuku S."/>
<person name="Cui X.-S."/>
<person name="Matsuoka S."/>
<person name="Cortez D."/>
<person name="Tamai K."/>
<person name="Luo G."/>
<person name="Carattini-Rivera S."/>
<person name="DeMayo F."/>
<person name="Bradley A."/>
<person name="Donehower L.A."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="10859164"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="2989" last="3002">
<title>Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.</title>
<authorList>
<person name="Tibbetts R.S."/>
<person name="Cortez D."/>
<person name="Brumbaugh K.M."/>
<person name="Scully R."/>
<person name="Livingston D."/>
<person name="Elledge S.J."/>
<person name="Abraham R.T."/>
</authorList>
<dbReference type="PubMed" id="11114888"/>
<dbReference type="DOI" id="10.1101/gad.851000"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-2327</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="47759" last="47762">
<title>Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress.</title>
<authorList>
<person name="Ward I.M."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="11673449"/>
<dbReference type="DOI" id="10.1074/jbc.C100569200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="Nature" volume="411" first="969" last="974">
<title>ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses.</title>
<authorList>
<person name="Bao S."/>
<person name="Tibbetts R.S."/>
<person name="Brumbaugh K.M."/>
<person name="Fang Y."/>
<person name="Richardson D.A."/>
<person name="Ali A."/>
<person name="Chen S.M."/>
<person name="Abraham R.T."/>
<person name="Wang X.-F."/>
</authorList>
<dbReference type="PubMed" id="11418864"/>
<dbReference type="DOI" id="10.1038/35082110"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD17</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="Science" volume="294" first="1713" last="1716">
<title>ATR and ATRIP: partners in checkpoint signaling.</title>
<authorList>
<person name="Cortez D."/>
<person name="Guntuku S."/>
<person name="Qin J."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="11721054"/>
<dbReference type="DOI" id="10.1126/science.1065521"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ATRIP</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Cell" volume="111" first="779" last="789">
<title>ATR regulates fragile site stability.</title>
<authorList>
<person name="Casper A.M."/>
<person name="Nghiem P."/>
<person name="Arlt M.F."/>
<person name="Glover T.W."/>
</authorList>
<dbReference type="PubMed" id="12526805"/>
<dbReference type="DOI" id="10.1016/S0092-8674(02)01113-3"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="1834" last="1843">
<title>Hypoxia links ATR and p53 through replication arrest.</title>
<authorList>
<person name="Hammond E.M."/>
<person name="Denko N.C."/>
<person name="Dorie M.J."/>
<person name="Abraham R.T."/>
<person name="Giaccia A.J."/>
</authorList>
<dbReference type="PubMed" id="11865061"/>
<dbReference type="DOI" id="10.1128/MCB.22.6.1834-1843.2002"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="6673" last="6678">
<title>Preferential binding of ATR protein to UV-damaged DNA.</title>
<authorList>
<person name="Uensal-Kacmaz K."/>
<person name="Makhov A.M."/>
<person name="Griffith J.D."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="12011431"/>
<dbReference type="DOI" id="10.1073/pnas.102167799"/>
</citation>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF LYS-2327</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Curr. Biol." volume="13" first="1047" last="1051">
<title>ATR kinase activity regulates the intranuclear translocation of ATR and RPA following ionizing radiation.</title>
<authorList>
<person name="Barr S.M."/>
<person name="Leung C.G."/>
<person name="Chang E.E."/>
<person name="Cimprich K.A."/>
</authorList>
<dbReference type="PubMed" id="12814551"/>
<dbReference type="DOI" id="10.1016/S0960-9822(03)00376-2"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASP-2475</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="30057" last="30062">
<title>Human claspin is required for replication checkpoint control.</title>
<authorList>
<person name="Chini C.C.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="12766152"/>
<dbReference type="DOI" id="10.1074/jbc.M301136200"/>
</citation>
<scope>INTERACTION WITH CLSPN</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="15387" last="15392">
<title>MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation.</title>
<authorList>
<person name="Wang Y."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="14657349"/>
<dbReference type="DOI" id="10.1073/pnas.2536810100"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MSH2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Science" volume="300" first="1542" last="1548">
<title>Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.</title>
<authorList>
<person name="Zou L."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="12791985"/>
<dbReference type="DOI" id="10.1126/science.1083430"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH RPA AND ATRIP</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Cancer Cell" volume="5" first="275" last="285">
<title>BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint.</title>
<authorList>
<person name="Dierov J."/>
<person name="Dierova R."/>
<person name="Carroll M."/>
</authorList>
<dbReference type="PubMed" id="15050919"/>
<dbReference type="DOI" id="10.1016/S1535-6108(04)00056-X"/>
</citation>
<scope>INTERACTION WITH BCR-ABL</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="9677" last="9680">
<title>UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress.</title>
<authorList>
<person name="Ward I.M."/>
<person name="Minn K."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="14742437"/>
<dbReference type="DOI" id="10.1074/jbc.C300554200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="16433" last="16440">
<title>Recruitment of the cell cycle checkpoint kinase ATR to chromatin during S-phase.</title>
<authorList>
<person name="Dart D.A."/>
<person name="Adams K.E."/>
<person name="Akerman I."/>
<person name="Lakin N.D."/>
</authorList>
<dbReference type="PubMed" id="14871897"/>
<dbReference type="DOI" id="10.1074/jbc.M314212200"/>
</citation>
<scope>DNA-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2004" name="Genes Dev." volume="18" first="1958" last="1963">
<title>ATR couples FANCD2 monoubiquitination to the DNA-damage response.</title>
<authorList>
<person name="Andreassen P.R."/>
<person name="D'Andrea A.D."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="15314022"/>
<dbReference type="DOI" id="10.1101/gad.1196104"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="3127" last="3138">
<title>Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway.</title>
<authorList>
<person name="Alderton G.K."/>
<person name="Joenje H."/>
<person name="Varon R."/>
<person name="Borglum A.D."/>
<person name="Jeggo P.A."/>
<person name="O'Driscoll M."/>
</authorList>
<dbReference type="PubMed" id="15496423"/>
<dbReference type="DOI" id="10.1093/hmg/ddh335"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="1292" last="1300">
<title>Quaternary structure of ATR and effects of ATRIP and replication protein A on its DNA binding and kinase activities.</title>
<authorList>
<person name="Uensal-Kacmaz K."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="14729973"/>
<dbReference type="DOI" id="10.1128/MCB.24.3.1292-1300.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH ATRIP AND RPA1</scope>
<scope>DNA-BINDING</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="10078" last="10083">
<title>Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases.</title>
<authorList>
<person name="Cortez D."/>
<person name="Glick G."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="15210935"/>
<dbReference type="DOI" id="10.1073/pnas.0403410101"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="Cell" volume="120" first="209" last="221">
<title>The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR.</title>
<authorList>
<person name="Park B.-J."/>
<person name="Kang J.W."/>
<person name="Lee S.W."/>
<person name="Choi S.-J."/>
<person name="Shin Y.K."/>
<person name="Ahn Y.H."/>
<person name="Choi Y.H."/>
<person name="Choi D."/>
<person name="Lee K.S."/>
<person name="Kim S."/>
</authorList>
<dbReference type="PubMed" id="15680327"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.11.054"/>
</citation>
<scope>INTERACTION WITH EEF1E1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Nature" volume="434" first="605" last="611">
<title>Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.</title>
<authorList>
<person name="Falck J."/>
<person name="Coates J."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="15758953"/>
<dbReference type="DOI" id="10.1038/nature03442"/>
</citation>
<scope>INTERACTION WITH ATRIP</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Cell" volume="124" first="943" last="955">
<title>TopBP1 activates the ATR-ATRIP complex.</title>
<authorList>
<person name="Kumagai A."/>
<person name="Lee J."/>
<person name="Yoo H.Y."/>
<person name="Dunphy W.G."/>
</authorList>
<dbReference type="PubMed" id="16530042"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.12.041"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Genes Dev." volume="22" first="587" last="600">
<title>Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.</title>
<authorList>
<person name="Sivasubramaniam S."/>
<person name="Sun X."/>
<person name="Pan Y.R."/>
<person name="Wang S."/>
<person name="Lee E.Y."/>
</authorList>
<dbReference type="PubMed" id="18283122"/>
<dbReference type="DOI" id="10.1101/gad.1627708"/>
</citation>
<scope>INTERACTION WITH CEP164</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2003" name="Nat. Genet." volume="33" first="497" last="501">
<title>A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.</title>
<authorList>
<person name="O'Driscoll M."/>
<person name="Ruiz-Perez V.L."/>
<person name="Woods C.G."/>
<person name="Jeggo P.A."/>
<person name="Goodship J.A."/>
</authorList>
<dbReference type="PubMed" id="12640452"/>
<dbReference type="DOI" id="10.1038/ng1129"/>
</citation>
<scope>INVOLVEMENT IN SCKL1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="9910" last="9919">
<title>Protein phosphatase 5 is required for ATR-mediated checkpoint activation.</title>
<authorList>
<person name="Zhang J."/>
<person name="Bao S."/>
<person name="Furumai R."/>
<person name="Kucera K.S."/>
<person name="Ali A."/>
<person name="Dean N.M."/>
<person name="Wang X.F."/>
</authorList>
<dbReference type="PubMed" id="16260606"/>
<dbReference type="DOI" id="10.1128/MCB.25.22.9910-9919.2005"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE</scope>
<scope>INTERACTION WITH PPP5C</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428 AND THR-1989</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Genes Dev." volume="24" first="1939" last="1950">
<title>A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability.</title>
<authorList>
<person name="Hurov K.E."/>
<person name="Cotta-Ramusino C."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="20810650"/>
<dbReference type="DOI" id="10.1101/gad.1934210"/>
</citation>
<scope>INTERACTION WITH TTI1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="Genes Dev." volume="24" first="2019" last="2030">
<title>Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes.</title>
<authorList>
<person name="Takai H."/>
<person name="Xie Y."/>
<person name="de Lange T."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="20801936"/>
<dbReference type="DOI" id="10.1101/gad.1956410"/>
</citation>
<scope>INTERACTION WITH TELO2</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="20109" last="20116">
<title>Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.</title>
<authorList>
<person name="Kaizuka T."/>
<person name="Hara T."/>
<person name="Oshiro N."/>
<person name="Kikkawa U."/>
<person name="Yonezawa K."/>
<person name="Takehana K."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
<person name="Mizushima N."/>
</authorList>
<dbReference type="PubMed" id="20427287"/>
<dbReference type="DOI" id="10.1074/jbc.M110.121699"/>
</citation>
<scope>INTERACTION WITH TELO2 AND TTI1</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="404" first="476" last="481">
<title>Protein phosphatase 5 is necessary for ATR-mediated DNA repair.</title>
<authorList>
<person name="Kang Y."/>
<person name="Cheong H.M."/>
<person name="Lee J.H."/>
<person name="Song P.I."/>
<person name="Lee K.H."/>
<person name="Kim S.Y."/>
<person name="Jun J.Y."/>
<person name="You H.J."/>
</authorList>
<dbReference type="PubMed" id="21144835"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.12.005"/>
</citation>
<scope>FUNCTION IN DNA REPAIR</scope>
<scope>PHOSPHORYLATION AT SER-428</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435; SER-436 AND THR-1989</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2016" name="Nat. Cell Biol." volume="18" first="1185" last="1195">
<title>ETAA1 acts at stalled replication forks to maintain genome integrity.</title>
<authorList>
<person name="Bass T.E."/>
<person name="Luzwick J.W."/>
<person name="Kavanaugh G."/>
<person name="Carroll C."/>
<person name="Dungrawala H."/>
<person name="Glick G.G."/>
<person name="Feldkamp M.D."/>
<person name="Putney R."/>
<person name="Chazin W.J."/>
<person name="Cortez D."/>
</authorList>
<dbReference type="PubMed" id="27723720"/>
<dbReference type="DOI" id="10.1038/ncb3415"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH ETAA1</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2016" name="Nat. Cell Biol." volume="18" first="1196" last="1207">
<title>Activation of the ATR kinase by the RPA-binding protein ETAA1.</title>
<authorList>
<person name="Haahr P."/>
<person name="Hoffmann S."/>
<person name="Tollenaere M.A."/>
<person name="Ho T."/>
<person name="Toledo L.I."/>
<person name="Mann M."/>
<person name="Bekker-Jensen S."/>
<person name="Raeschle M."/>
<person name="Mailand N."/>
</authorList>
<dbReference type="PubMed" id="27723717"/>
<dbReference type="DOI" id="10.1038/ncb3422"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH ETAA1</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ALA-64; TYR-90; ASN-297; ILE-316; MET-959; HIS-1087; GLY-1213; PRO-1488; ASN-1607; SER-1612; GLY-2002; ALA-2120; ASP-2132; ILE-2233; GLN-2425; ALA-2434; LYS-2438 AND GLN-2537</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2012" name="Am. J. Hum. Genet." volume="90" first="511" last="517">
<title>Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome.</title>
<authorList>
<person name="Tanaka A."/>
<person name="Weinel S."/>
<person name="Nagy N."/>
<person name="O'Driscoll M."/>
<person name="Lai-Cheong J.E."/>
<person name="Kulp-Shorten C.L."/>
<person name="Knable A."/>
<person name="Carpenter G."/>
<person name="Fisher S.A."/>
<person name="Hiragun M."/>
<person name="Yanase Y."/>
<person name="Hide M."/>
<person name="Callen J."/>
<person name="McGrath J.A."/>
</authorList>
<dbReference type="PubMed" id="22341969"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2012.01.007"/>
</citation>
<scope>VARIANT FCTCS ARG-2144</scope>
</reference>
<comment type="function">
<text evidence="9 10 11 12 13 15 16 17 19 22 23 24 25 26 29 30 31 34 41 43 44 47 48 50">Serine/threonine protein kinase which activates checkpoint signaling upon genotoxic stresses such as ionizing radiation (IR), ultraviolet light (UV), or DNA replication stalling, thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates BRCA1, CHEK1, MCM2, RAD17, RPA2, SMC1 and p53/TP53, which collectively inhibit DNA replication and mitosis and promote DNA repair, recombination and apoptosis. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX at sites of DNA damage, thereby regulating DNA damage response mechanism. Required for FANCD2 ubiquitination. Critical for maintenance of fragile site stability and efficient regulation of centrosome duplication.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="10">
<name>Mn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29035"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="9 25 35 43 44 49">Serine/threonine-protein kinase activity is directly stimulated by TOPBP1 (PubMed:16530042). ATR kinase activity is also directly activated by ETAA1, independently of TOPBP1 (PubMed:27723720, PubMed:27723717). Activated by DNA and inhibited by BCR-ABL oncogene (PubMed:10597277). Slightly activated by ATRIP (PubMed:14729973). Inhibited by caffeine, wortmannin and LY294002 (PubMed:9766667).</text>
</comment>
<comment type="subunit">
<text evidence="3 8 13 16 21 22 24 25 28 32 33 34 37 38 39 40">Interacts with ATRIP; forming a heterodimer with ATRIP (PubMed:11721054). Binds to DNA, and to UV-damaged DNA with higher affinity. Interacts with RAD17, MSH2 and HDAC2. Present in a complex containing ATRIP and RPA-coated single-stranded DNA. Present in a complex containing CHD4 and HDAC2. Interacts with BCR-ABL after genotoxic stress. Interacts with EEF1E1. This interaction is enhanced by UV irradiation. Interacts with CLSPN and CEP164. Interacts with TELO2 and TTI1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968983"/>
<interactant intactId="EBI-374880">
<id>Q99459</id>
<label>CDC5L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968983"/>
<interactant intactId="EBI-1383449">
<id>P50750</id>
<label>CDK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968983"/>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968983"/>
<interactant intactId="EBI-1055680">
<id>O43156</id>
<label>TTI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="12 16 17 23 27 34 37 46">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Nucleus</location>
<location evidence="4">PML body</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Chromosome</location>
</subcellularLocation>
<text>Depending on the cell type, it can also be found in PML nuclear bodies. Recruited to chromatin during S-phase. Redistributes to discrete nuclear foci upon DNA damage, hypoxia or replication fork stalling.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13535-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13535-2</id>
<name>2</name>
<sequence type="described" ref="VSP_013305 VSP_013304"/>
</isoform>
<isoform>
<id>Q13535-3</id>
<name>3</name>
<sequence type="described" ref="VSP_036907 VSP_036908"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="14 45 46">Ubiquitous, with highest expression in testis. Isoform 2 is found in pancreas, placenta and liver but not in heart, testis and ovary.</text>
</comment>
<comment type="PTM">
<text evidence="41">Phosphorylated; autophosphorylates in vitro.</text>
</comment>
<comment type="disease" evidence="20">
<disease id="DI-01008">
<name>Seckel syndrome 1</name>
<acronym>SCKL1</acronym>
<description>A rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation.</description>
<dbReference type="MIM" id="210600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="42">
<disease id="DI-03427">
<name>Cutaneous telangiectasia and cancer syndrome, familial</name>
<acronym>FCTCS</acronym>
<description>A disease characterized by cutaneous telangiectases in infancy with patchy alopecia over areas of affected skin, thinning of the lateral eyebrows, and mild dental and nail anomalies. Affected individuals are at increased risk of developing oropharyngeal cancer, and other malignancies have been reported as well.</description>
<dbReference type="MIM" id="614564"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="53">Belongs to the PI3/PI4-kinase family. ATM subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ATRID728ch3q23.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="Y09077">
<property type="protein sequence ID" value="CAA70298.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U76308">
<property type="protein sequence ID" value="AAC50929.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U49844">
<property type="protein sequence ID" value="AAC50405.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF325699">
<property type="protein sequence ID" value="AAK26749.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB208847">
<property type="protein sequence ID" value="BAD92084.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3124.1">
<molecule id="Q13535-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001175.2">
<molecule id="Q13535-1"/>
<property type="nucleotide sequence ID" value="NM_001184.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016862132.1">
<molecule id="Q13535-2"/>
<property type="nucleotide sequence ID" value="XM_017006643.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.271791"/>
<dbReference type="ProteinModelPortal" id="Q13535"/>
<dbReference type="BioGrid" id="107027">
<property type="interactions" value="111"/>
</dbReference>
<dbReference type="DIP" id="DIP-35308N"/>
<dbReference type="IntAct" id="Q13535">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="MINT" id="MINT-194575"/>
<dbReference type="STRING" id="9606.ENSP00000343741"/>
<dbReference type="BindingDB" id="Q13535"/>
<dbReference type="ChEMBL" id="CHEMBL5024"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1935"/>
<dbReference type="iPTMnet" id="Q13535"/>
<dbReference type="PhosphoSitePlus" id="Q13535"/>
<dbReference type="BioMuta" id="ATR"/>
<dbReference type="DMDM" id="62286460"/>
<dbReference type="EPD" id="Q13535"/>
<dbReference type="MaxQB" id="Q13535"/>
<dbReference type="PaxDb" id="Q13535"/>
<dbReference type="PeptideAtlas" id="Q13535"/>
<dbReference type="PRIDE" id="Q13535"/>
<dbReference type="DNASU" id="545"/>
<dbReference type="Ensembl" id="ENST00000350721">
<molecule id="Q13535-1"/>
<property type="protein sequence ID" value="ENSP00000343741"/>
<property type="gene ID" value="ENSG00000175054"/>
</dbReference>
<dbReference type="GeneID" id="545"/>
<dbReference type="KEGG" id="hsa:545"/>
<dbReference type="UCSC" id="uc003eux.5">
<molecule id="Q13535-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="545"/>
<dbReference type="DisGeNET" id="545"/>
<dbReference type="GeneCards" id="ATR"/>
<dbReference type="GeneReviews" id="ATR"/>
<dbReference type="H-InvDB" id="HIX0030886"/>
<dbReference type="HGNC" id="HGNC:882">
<property type="gene designation" value="ATR"/>
</dbReference>
<dbReference type="HPA" id="HPA054320"/>
<dbReference type="MalaCards" id="ATR"/>
<dbReference type="MIM" id="210600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601215">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614564">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13535"/>
<dbReference type="OpenTargets" id="ENSG00000175054"/>
<dbReference type="Orphanet" id="313846">
<property type="disease" value="Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="808">
<property type="disease" value="Seckel syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA74"/>
<dbReference type="eggNOG" id="KOG0890">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5032">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00830000128321"/>
<dbReference type="HOGENOM" id="HOG000034221"/>
<dbReference type="HOVERGEN" id="HBG050619"/>
<dbReference type="InParanoid" id="Q13535"/>
<dbReference type="KO" id="K06640"/>
<dbReference type="OMA" id="WRRFPEH"/>
<dbReference type="OrthoDB" id="EOG091G013Q"/>
<dbReference type="PhylomeDB" id="Q13535"/>
<dbReference type="TreeFam" id="TF101183"/>
<dbReference type="Reactome" id="R-HSA-1221632">
<property type="pathway name" value="Meiotic synapsis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176187">
<property type="pathway name" value="Activation of ATR in response to replication stress"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371453">
<property type="pathway name" value="Regulation of HSF1-mediated heat shock response"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685938">
<property type="pathway name" value="HDR through Single Strand Annealing (SSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6783310">
<property type="pathway name" value="Fanconi Anemia Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="SignaLink" id="Q13535"/>
<dbReference type="SIGNOR" id="Q13535"/>
<dbReference type="ChiTaRS" id="ATR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Ataxia_telangiectasia_and_Rad3_related"/>
<dbReference type="GenomeRNAi" id="545"/>
<dbReference type="PRO" id="PR:Q13535"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000175054"/>
<dbReference type="CleanEx" id="HS_ATR"/>
<dbReference type="ExpressionAtlas" id="Q13535">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13535">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032405">
<property type="term" value="F:MutLalpha complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032407">
<property type="term" value="F:MutSalpha complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071480">
<property type="term" value="P:cellular response to gamma radiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097695">
<property type="term" value="P:establishment of macromolecular complex localization to telomere"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097694">
<property type="term" value="P:establishment of RNA localization to telomere"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0036297">
<property type="term" value="P:interstrand cross-link repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008156">
<property type="term" value="P:negative regulation of DNA replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043517">
<property type="term" value="P:positive regulation of DNA damage response, signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904884">
<property type="term" value="P:positive regulation of telomerase catalytic core complex assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032212">
<property type="term" value="P:positive regulation of telomere maintenance via telomerase"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070198">
<property type="term" value="P:protein localization to chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900034">
<property type="term" value="P:regulation of cellular response to heat"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090399">
<property type="term" value="P:replicative senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.1070.11">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.10.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011989">
<property type="entry name" value="ARM-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003152">
<property type="entry name" value="FATC_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR021133">
<property type="entry name" value="HEAT_type_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000403">
<property type="entry name" value="PI3/4_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018936">
<property type="entry name" value="PI3/4_kinase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR003151">
<property type="entry name" value="PIK-rel_kinase_FAT"/>
</dbReference>
<dbReference type="InterPro" id="IPR014009">
<property type="entry name" value="PIK_FAT"/>
</dbReference>
<dbReference type="InterPro" id="IPR011990">
<property type="entry name" value="TPR-like_helical_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR012993">
<property type="entry name" value="UME"/>
</dbReference>
<dbReference type="Pfam" id="PF02259">
<property type="entry name" value="FAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02260">
<property type="entry name" value="FATC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00454">
<property type="entry name" value="PI3_PI4_kinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08064">
<property type="entry name" value="UME"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01343">
<property type="entry name" value="FATC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00146">
<property type="entry name" value="PI3Kc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00802">
<property type="entry name" value="UME"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48452">
<property type="entry name" value="SSF48452"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51189">
<property type="entry name" value="FAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51190">
<property type="entry name" value="FATC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50077">
<property type="entry name" value="HEAT_REPEAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00916">
<property type="entry name" value="PI3_4_KINASE_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50290">
<property type="entry name" value="PI3_4_KINASE_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0464">Manganese</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Serine/threonine-protein kinase ATR" id="PRO_0000088844">
<location>
<begin position="1"/>
<end position="2644"/>
</location>
</feature>
<feature type="repeat" description="HEAT 1">
<location>
<begin position="799"/>
<end position="835"/>
</location>
</feature>
<feature type="repeat" description="HEAT 2">
<location>
<begin position="1329"/>
<end position="1365"/>
</location>
</feature>
<feature type="domain" description="FAT" evidence="6">
<location>
<begin position="1640"/>
<end position="2185"/>
</location>
</feature>
<feature type="domain" description="PI3K/PI4K" evidence="5">
<location>
<begin position="2322"/>
<end position="2567"/>
</location>
</feature>
<feature type="domain" description="FATC" evidence="6 7">
<location>
<begin position="2612"/>
<end position="2644"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 41">
<location>
<position position="428"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="435"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="436"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="1 2">
<location>
<position position="1989"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_013305" evidence="51">
<original>E</original>
<variation>D</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_013304" evidence="51">
<location>
<begin position="451"/>
<end position="514"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_036907" evidence="52">
<original>AKTHVLDIEQRLQGVIKTRNRVT</original>
<variation>VSRRYSLIWAVVLISTNELDMQL</variation>
<location>
<begin position="2588"/>
<end position="2610"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_036908" evidence="52">
<location>
<begin position="2611"/>
<end position="2644"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35306038." id="VAR_041584" evidence="36">
<original>T</original>
<variation>A</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897763." id="VAR_041585" evidence="36">
<original>H</original>
<variation>Y</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2227928." id="VAR_050532">
<original>M</original>
<variation>T</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229033." id="VAR_041586" evidence="36">
<original>K</original>
<variation>N</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897764." id="VAR_041587" evidence="36">
<original>V</original>
<variation>I</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28910271." id="VAR_041588" evidence="36">
<original>V</original>
<variation>M</variation>
<location>
<position position="959"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34253059." id="VAR_041589" evidence="36">
<original>Y</original>
<variation>H</variation>
<location>
<position position="1087"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34766606." id="VAR_041590" evidence="36">
<original>S</original>
<variation>G</variation>
<location>
<position position="1213"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung squamous cell carcinoma sample; somatic mutation." id="VAR_041591" evidence="36">
<original>A</original>
<variation>P</variation>
<location>
<position position="1488"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34124242." id="VAR_050533">
<original>I</original>
<variation>V</variation>
<location>
<position position="1526"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55724025." id="VAR_041592" evidence="36">
<original>S</original>
<variation>N</variation>
<location>
<position position="1607"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55894265." id="VAR_041593" evidence="36">
<original>N</original>
<variation>S</variation>
<location>
<position position="1612"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma sample; somatic mutation." id="VAR_041594" evidence="36">
<original>A</original>
<variation>G</variation>
<location>
<position position="2002"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35134774." id="VAR_041595" evidence="36">
<original>G</original>
<variation>A</variation>
<location>
<position position="2120"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28910273." id="VAR_041596" evidence="36">
<original>Y</original>
<variation>D</variation>
<location>
<position position="2132"/>
</location>
</feature>
<feature type="sequence variant" description="In FCTCS; dbSNP:rs387906797." id="VAR_067919" evidence="42">
<original>Q</original>
<variation>R</variation>
<location>
<position position="2144"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung large cell carcinoma sample; somatic mutation." id="VAR_041597" evidence="36">
<original>S</original>
<variation>I</variation>
<location>
<position position="2233"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229032." id="VAR_041598" evidence="36">
<original>R</original>
<variation>Q</variation>
<location>
<position position="2425"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33972295." id="VAR_041599" evidence="36">
<original>P</original>
<variation>A</variation>
<location>
<position position="2434"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast pleomorphic lobular carcinoma sample; somatic mutation." id="VAR_041600" evidence="36">
<original>E</original>
<variation>K</variation>
<location>
<position position="2438"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast infiltrating ductal carcinoma sample; somatic mutation." id="VAR_041601" evidence="36">
<original>E</original>
<variation>Q</variation>
<location>
<position position="2537"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="12 18 50">
<original>K</original>
<variation>R</variation>
<location>
<position position="2327"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity; increases sensitivity to IR and impairs translocation to nuclear foci upon DNA damage." evidence="23 47 50">
<original>D</original>
<variation>A</variation>
<location>
<position position="2475"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity; reduces cell viability, augments sensitivity to IR and UV." evidence="9 48">
<original>D</original>
<variation>E</variation>
<location>
<position position="2494"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA70298/AAC50929." ref="1" evidence="53">
<original>A</original>
<variation>R</variation>
<location>
<position position="92"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9JKK8"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00269"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00534"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00535"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10545197"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10597277"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10608806"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10859164"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11114888"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11418864"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11470508"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11673449"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11721054"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11865061"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12011431"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12526805"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12640452"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12766152"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12791985"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12814551"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14657349"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14729973"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14742437"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14871897"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15050919"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15210935"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15314022"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15496423"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15680327"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15758953"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16260606"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16530042"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18283122"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20427287"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20801936"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20810650"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21144835"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22341969"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27723717"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27723720"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8610130"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8843195"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9427750"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9636169"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9766667"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9925639"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11470508"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="53" type="ECO:0000305"/>
<sequence length="2644" mass="301367" checksum="11BC22297FB9A802" modified="2004-07-05" version="3">
MGEHGLELASMIPALRELGSATPEEYNTVVQKPRQILCQFIDRILTDVNVVAVELVKKTD
SQPTSVMLLDFIQHIMKSSPLMFVNVSGSHEAKGSCIEFSNWIITRLLRIAATPSCHLLH
KKICEVICSLLFLFKSKSPAIFGVLTKELLQLFEDLVYLHRRNVMGHAVEWPVVMSRFLS
QLDEHMGYLQSAPLQLMSMQNLEFIEVTLLMVLTRIIAIVFFRRQELLLWQIGCVLLEYG
SPKIKSLAISFLTELFQLGGLPAQPASTFFSSFLELLKHLVEMDTDQLKLYEEPLSKLIK
TLFPFEAEAYRNIEPVYLNMLLEKLCVMFEDGVLMRLKSDLLKAALCHLLQYFLKFVPAG
YESALQVRKVYVRNICKALLDVLGIEVDAEYLLGPLYAALKMESMEIIEEIQCQTQQENL
SSNSDGISPKRRRLSSSLNPSKRAPKQTEEIKHVDMNQKSILWSALKQKAESLQISLEYS
GLKNPVIEMLEGIAVVLQLTALCTVHCSHQNMNCRTFKDCQHKSKKKPSVVITWMSLDFY
TKVLKSCRSLLESVQKLDLEATIDKVVKIYDALIYMQVNSSFEDHILEDLCGMLSLPWIY
SHSDDGCLKLTTFAANLLTLSCRISDSYSPQAQSRCVFLLTLFPRRIFLEWRTAVYNWAL
QSSHEVIRASCVSGFFILLQQQNSCNRVPKILIDKVKDDSDIVKKEFASILGQLVCTLHG
MFYLTSSLTEPFSEHGHVDLFCRNLKATSQHECSSSQLKASVCKPFLFLLKKKIPSPVKL
AFIDNLHHLCKHLDFREDETDVKAVLGTLLNLMEDPDKDVRVAFSGNIKHILESLDSEDG
FIKELFVLRMKEAYTHAQISRNNELKDTLILTTGDIGRAAKGDLVPFALLHLLHCLLSKS
ASVSGAAYTEIRALVAAKSVKLQSFFSQYKKPICQFLVESLHSSQMTALPNTPCQNADVR
KQDVAHQREMALNTLSEIANVFDFPDLNRFLTRTLQVLLPDLAAKASPAASALIRTLGKQ
LNVNRREILINNFKYIFSHLVCSCSKDELERALHYLKNETEIELGSLLRQDFQGLHNELL
LRIGEHYQQVFNGLSILASFASSDDPYQGPRDIISPELMADYLQPKLLGILAFFNMQLLS
SSVGIEDKKMALNSLMSLMKLMGPKHVSSVRVKMMTTLRTGLRFKDDFPELCCRAWDCFV
RCLDHACLGSLLSHVIVALLPLIHIQPKETAAIFHYLIIENRDAVQDFLHEIYFLPDHPE
LKKIKAVLQEYRKETSESTDLQTTLQLSMKAIQHENVDVRIHALTSLKETLYKNQEKLIK
YATDSETVEPIISQLVTVLLKGCQDANSQARLLCGECLGELGAIDPGRLDFSTTETQGKD
FTFVTGVEDSSFAYGLLMELTRAYLAYADNSRAQDSAAYAIQELLSIYDCREMETNGPGH
QLWRRFPEHVREILEPHLNTRYKSSQKSTDWSGVKKPIYLSKLGSNFAEWSASWAGYLIT
KVRHDLASKIFTCCSIMMKHDFKVTIYLLPHILVYVLLGCNQEDQQEVYAEIMAVLKHDD
QHTINTQDIASDLCQLSTQTVFSMLDHLTQWARHKFQALKAEKCPHSKSNRNKVDSMVST
VDYEDYQSVTRFLDLIPQDTLAVASFRSKAYTRAVMHFESFITEKKQNIQEHLGFLQKLY
AAMHEPDGVAGVSAIRKAEPSLKEQILEHESLGLLRDATACYDRAIQLEPDQIIHYHGVV
KSMLGLGQLSTVITQVNGVHANRSEWTDELNTYRVEAAWKLSQWDLVENYLAADGKSTTW
SVRLGQLLLSAKKRDITAFYDSLKLVRAEQIVPLSAASFERGSYQRGYEYIVRLHMLCEL
EHSIKPLFQHSPGDSSQEDSLNWVARLEMTQNSYRAKEPILALRRALLSLNKRPDYNEMV
GECWLQSARVARKAGHHQTAYNALLNAGESRLAELYVERAKWLWSKGDVHQALIVLQKGV
ELCFPENETPPEGKNMLIHGRAMLLVGRFMEETANFESNAIMKKYKDVTACLPEWEDGHF
YLAKYYDKLMPMVTDNKMEKQGDLIRYIVLHFGRSLQYGNQFIYQSMPRMLTLWLDYGTK
AYEWEKAGRSDRVQMRNDLGKINKVITEHTNYLAPYQFLTAFSQLISRICHSHDEVFVVL
MEIIAKVFLAYPQQAMWMMTAVSKSSYPMRVNRCKEILNKAIHMKKSLEKFVGDATRLTD
KLLELCNKPVDGSSSTLSMSTHFKMLKKLVEEATFSEILIPLQSVMIPTLPSILGTHANH
ASHEPFPGHWAYIAGFDDMVEILASLQKPKKISLKGSDGKFYIMMCKPKDDLRKDCRLME
FNSLINKCLRKDAESRRRELHIRTYAVIPLNDECGIIEWVNNTAGLRPILTKLYKEKGVY
MTGKELRQCMLPKSAALSEKLKVFREFLLPRHPPIFHEWFLRTFPDPTSWYSSRSAYCRS
TAVMSMVGYILGLGDRHGENILFDSLTGECVHVDFNCLFNKGETFEVPEIVPFRLTHNMV
NGMGPMGTEGLFRRACEVTMRLMRDQREPLMSVLKTFLHDPLVEWSKPVKGHSKAPLNET
GEVVNEKAKTHVLDIEQRLQGVIKTRNRVTGLPLSIEGHVHYLIQEATDENLLCQMYLGW
TPYM
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>